O
DHR icon

OrbiMed’s Danaher DHR Stock Holding History

OrbiMed’s Portfolio DHR Stock Details DHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-265,800
Closed -$50.4M – 138
2026
Q1 		$50.4M Sell
265,800
-34,000
-11% -$7.24M 1% 33
2025
Q4 		$68.6M Buy
299,800
+36,700
+14% +$8.07M 1.4% 21
2025
Q3 		$52.2M Buy
+263,100
New +$52.4M 1.23% 28
2020
Q1 		– Sell
-720,679
Closed -$98.1M – 148
2019
Q4 		$98.1M Buy
+720,679
New +$91.1M 1.4% 26

Other funds holding DHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

OrbiMed's DHR Position: Q2 2026 in Review

OrbiMed sold out of Danaher (DHR) in Q2 2026, closing a stake of 265,800 shares — an estimated $50.4M sold.

OrbiMed first reported a position in DHR in Q4 2019 and held it in 4 quarters. The position peaked at $98.1M in Q4 2019. 2,109 funds tracked by Wall St. Rank hold DHR as of Q2 2026.

  • OrbiMed reported no remaining Danaher position as of Q2 2026 after selling out during the quarter.
  • OrbiMed sold 265,800 Danaher shares in Q2 2026, an estimated $50.4M.
  • OrbiMed first reported a position in Danaher in Q4 2019 and held it in 4 quarters.
  • OrbiMed's Danaher position peaked at $98.1M in Q4 2019.
  • 2,109 funds tracked by Wall St. Rank held Danaher as of Q2 2026.

Based on OrbiMed's 13F filing for Q2 2026, filed 14 Aug 2026.